Researchers at the Perelman School of Medicine demonstrated the potential of a CAR-T gel in eliminating residual cancer cells after surgery.
Researchers at the Perelman School of Medicine demonstrated the potential of a CAR-T gel in eliminating residual cancer cells after surgery.